Clinical-stage company developing first-in-class therapies for precision neuroregeneration including myelin restoration, synaptogenesis and axonal repair with applications in hearing loss and multiple sclerosis.
Clinical-stage company developing first-in-class therapies for precision neuroregeneration including myelin restoration, synaptogenesis and axonal repair with applications in hearing loss and multiple sclerosis.
© 2023 Red Tree Venture Capital. All Rights Reserved.
2055 Woodside Road, Suite 270
Redwood City, CA 94061
(650) 492-7900